Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

iRhythm Technologies Inc (IRTC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow iRhythm Tech's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
112.94 -3.48    -2.99%
11:20:12 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 39,084
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 111.49 - 114.42
iRhythm Tech 112.94 -3.48 -2.99%

iRhythm Technologies Inc Company Profile

 
Get an in-depth profile of iRhythm Technologies Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

2000

Equity Type

ORD

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Contact Information

Address 699 8th Street Suite 600
San Francisco, 94103
United States
Phone 415 632 5700
Fax -

Top Executives

Name Age Since Title
Abhijit Y. Talwalkar 60 2016 Independent Chairman
Raymond W. Scott 74 2013 Independent Director
Bruce George Bodaken 70 2017 Independent Director
Mark J. Rubash 64 2016 Independent Director
Quentin S. Blackford 43 2021 President, CEO & Director
Brian B. Yoor 54 2023 Independent Director
Michael J. Mirro 75 - Medical Director & Member of Scientific Advisory Board
R. Hardwin Mead - - Medical Director & Member of Scientific Advisory Board
Ralph D. Snyderman 84 2017 Independent Director
Cathleen Noel Bairey Merz 68 2018 Independent Director
Jay Alexander - - Medical Director & Member of Scientific Advisory Board
Karen L. Ling 60 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IRTC Comments

Write your thoughts about iRhythm Technologies Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Leonardo Argentieri
Leonardo Argentieri Jun 03, 2021 3:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy this dip
ritchie lee
ritchie lee Jun 02, 2021 10:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow. just accidently stumble on this stock. whats happening??
fabio frontini
fronte Jun 02, 2021 10:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Over reaction due to ceo stepping back due to personal reasons. They are now looking for a new ceo while the previous one will remain available for the transation process
Eldar Hamzayev
Eldar Hamzayev Jun 02, 2021 10:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CEO stepped away, before this they downgraded repeatedly the revenue forecast several times. just read the news )
fabio frontini
fronte May 07, 2021 10:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now just hold lol
fabio frontini
fronte Apr 21, 2021 5:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy and hold
Augusto Ferrari
Augusto Ferrari Apr 21, 2021 5:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yep but is realistic to see this stock rise again among 1 year more or lessr less
DorkRain Tostie
DorkRain Tostie Apr 13, 2021 4:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
"iRhythm stated that these new rates would negatively impact its first-quarter revenue by $13 million. The company also said it" https://www.fool.com/investing/2021/04/12/why-irhythm-technologies-stock-is-crashing-today/wouldn't be able to provide its Zio XT service for cardiac monitoring to the Medicare fee-for-service segment if the rates aren't increased.
Jan Nordenbæk Pedersen
Jan Nordenbæk Pedersen Apr 12, 2021 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is happening?
Jan Houston
Jan Houston Apr 12, 2021 11:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why the drop?
Yo Rose
Yo Rose Apr 12, 2021 9:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go in the ****
Suc Madic
Suc_Madic Apr 12, 2021 8:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what happen?
Ab High
Ab High Apr 12, 2021 6:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email